pyoderma gangrenosum, and acne (PAPA); and pyoderma gangrenosum, acne, and suppurativa hidradenitis (PASH). In a 2023 study, researchers evaluated the demographic factors of acne fulminans in 212 ...
The ongoing studies, including the pyoderma gangrenosum study, are expected to yield important data soon, which could further strengthen the company’s position. With a robust financial footing ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback